A critical cGMP requirement is the establishment of controls to ensure quality and safety of investigational drug products, 9 including comprehensive quality systems that apply to all aspects of ...
Viral vectors dominate gene therapy, with lentivirus, adenovirus, and AAV being key players, each with unique advantages and limitations. Non-viral vectors, such as lipid nanoparticles and GalNAc, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback